Testing effectiveness (Phase 2)UnknownNCT00168870What this trial is testingStudy of Metastatic Ocular MelanomaWho this might be right forOcular Melanoma Charite University, Berlin, Germany 48
Testing effectiveness (Phase 2)Ended earlyNCT01533948What this trial is testingAxitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forExtraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma+9 more Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Ended earlyNCT04589832What this trial is testingStudy of PAC-1 and Entrectinib for Patients With Metastatic Uveal MelanomaWho this might be right forUveal Melanoma Arkadiusz Z. Dudek, MD 6
Not applicableStudy completedNCT02849145What this trial is testingEvaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)Who this might be right forUveal Melanoma Institut Curie 60
Early research (Phase 1)Ended earlyNCT04879017What this trial is testingFHD-286 in Subjects With Metastatic Uveal MelanomaWho this might be right forMetastatic Uveal Melanoma Foghorn Therapeutics Inc. 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868What this trial is testingAPG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsWho this might be right forUnresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more Ascentage Pharma Group Inc. 230
Testing effectiveness (Phase 2)Active Not RecruitingNCT01587352What this trial is testingVorinostat in Treating Patients With Metastatic Melanoma of the EyeWho this might be right forMetastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7 National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02363283What this trial is testingGlembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal MelanomaWho this might be right forRecurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7 National Cancer Institute (NCI) 37
Early research (Phase 1)Ended earlyNCT03865212What this trial is testingModified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more Mayo Clinic 12
Large-scale testing (Phase 3)Looking for participantsNCT06581406What this trial is testingA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaWho this might be right forMetastatic Uveal Melanoma Replimune, Inc. 280
Early research (Phase 1)Active Not RecruitingNCT05640193What this trial is testingLN-144 in People With Metastatic Melanoma to the BrainWho this might be right forMetastatic Melanoma Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07627698What this trial is testingDual-Target CSPG4/GD2 CAR-NK Cells for Advanced MelanomaWho this might be right forUnresectable MelanomaMetastatic Cutaneous MelanomaMetastatic Uveal Melanoma Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Large-scale testing (Phase 3)Looking for participantsNCT07804186What this trial is testingStudy of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal MelanomaWho this might be right forUveal Melanoma IDEAYA Biosciences 450
Early research (Phase 1)Study completedNCT05628883What this trial is testingProof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory MelanomaWho this might be right forMetastatic MelanomaUnresectable MelanomaAcral Melanoma+7 more H. Lee Moffitt Cancer Center and Research Institute 17
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00313508What this trial is testingDendritic Cell Vaccination During Lymphoid ReconstructionWho this might be right forIntraocular MelanomaMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)UnknownNCT02654821What this trial is testingStudy With T-cel Receptor Gene Therapy in Metastatic MelanomaWho this might be right forStage IV Skin MelanomaEye; Melanoma The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05415072What this trial is testingA Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant MelanomasWho this might be right forMetastatic Uveal Melanoma Novartis Pharmaceuticals 66
Early research (Phase 1)Ended earlyNCT02601378What this trial is testingA Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.Who this might be right forUveal Melanoma Novartis Pharmaceuticals 107